Glyburide treatment in gestational diabetes is associated with increased placental glucose transporter 1 expression and higher birth weight

This data is the first to show that glyburide increases GLUT1 expression in syncytiotrophoblast MVM and BM in GDM pregnancies, and may promote transplacental glucose delivery contributing to fetal overgrowth.